cardiology current awareness newsletter may 2016 · 18. levine gn, bates er, blankenship jc, et al....
TRANSCRIPT
Cardiology
Current Awareness Newsletter
May 2016
Outreach Your Outreach Librarian can help facilitate evidence-based practise for
all PICU staff, as well as assisting with academic study and research. We can help with literature searching, obtaining journal articles and
books, and setting up individual current awareness alerts.
Literature Searching We provide a literature searching service for any library member. For those embarking on their own research it is advisable to book some
time with one of the librarians for a 1 to 1 session where we can guide you through the process of creating a well-focused literature research and introduce you to the health databases access via NHS Evidence.
Critical Appraisal Training We also offer one-to-one or small group training in literature
searching, accessing electronic journals, and critical appraisal/Statistics. These are essential courses that teach how to
interpret clinical papers.
For more information, email: [email protected]
Books Books can be searched for using SWIMS our online catalogue at
www.swims.nhs.uk. Books and journals that are not available on site or electronically may be requested from other locations. Please email
requests to: [email protected]
Contents
Cardiology Journals (TOC’s)
New NICE Guidance
Latest relevant Systematic Reviews from
the Cochrane Library
Recent research from Research Gate
New activity in Uptodate
Literature Search
Tables of Contents from relevant journals If you require full articles please email: [email protected]
Journal of the American College of Cardiology Vol. 67, No. 19, May 17, 2016
Circulation Volume 133, Issue 19, May 10 2016 European Heart Journal Volume 37, Issue 18, 7 May 2016
New Nice Guidance No new guidelines
Latest relevant Systematic Reviews from the
Cochrane Library
Table of Contents: Issue 5, 2016
Methotrexate for polymyalgia rheumatica Nataliya Milman, Samuel L Whittle, Catherine L Hill, Jinane El Sayad, George A Wells Online Publication Date:
Methotrexate for giant cell arteritis Nataliya Milman, Catherine L Hill, Samuel L Whittle, Jinane El Sayad, George A Wells Online Publication Date: May 2016
Recent Research from Research Gate
Click here Bristol Heart Institute
UptoDate What's new in cardiovascular medicine Authors Gordon M Saperia, MD, FACC Susan B Yeon, MD, JD, FACC Brian C Downey, MD, FACC Contributor disclosures
All topics are updated as new evidence becomes available and our peer review process is complete. Literature review current through: Apr 2016. | This topic last updated: May 09, 2016.
The following represent additions to UpToDate from the past six months that were considered by the
editors and authors to be of particular interest. The most recent What's New entries are at the top of
each subsection.
ARRHYTHMIAS
Radiofrequency catheter ablation for patients with an ICD and recurrent shocks (May 2016)
Patients with an implantable cardioverter-defibrillator (ICD) who have recurrent ICD shocks due to
ventricular tachycardia (VT) experience significant discomfort and reduced quality of life, and the
effectiveness of antiarrhythmic drug therapy to prevent VT is limited. In the VANISH trial, a
multicenter, nonblinded trial of patients with prior myocardial infarction and an ICD who had at least
one episode of VT within the preceding six months while on antiarrhythmic drug therapy, patients
were randomized to radiofrequency catheter ablation (RFA) or escalated antiarrhythmic therapy [1].
Over a mean follow-up of 28 months, patients in the RFA group had significant reduction in the
composite primary outcome of death, VT storm, or appropriate ICD shocks, although there was no
difference in mortality alone. RFA is an option for reducing the morbidity associated with recurrent ICD
shocks in patients with ischemic cardiomyopathy who have recurrent VT despite antiarrhythmic drug
therapy. (See "Sustained monomorphic ventricular tachycardia in patients with a prior myocardial
infarction: Treatment and prognosis", section on 'Efficacy of catheter ablation'.)
CORONARY ARTERY BYPASS GRAFT SURGERY
Preoperative statin therapy does not decrease the risk of perioperative AF (May 2016)
Perioperative atrial fibrillation (AF) is common with cardiac surgery. Statins have been prescribed as
preventive therapy based on relatively weak evidence. In the STICS trial, 1922 patients in sinus
rhythm scheduled for elective cardiac surgery were randomly assigned to receive perioperative
rosuvastatin (20 mg daily) or placebo up to eight days before surgery [9]. There was no difference in
the rate of perioperative AF but a significant increase in the risk of acute kidney injury in the
rosuvastatin group. Based on available evidence, we do not start statins before cardiac surgery in
most cases. (See "Atrial fibrillation and flutter after cardiac surgery", section on 'Ineffective or possibly
effective therapies'.)
REFERENCES
1. Sapp JL, Wells GA, Parkash R, et al. Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. N Engl J Med 2016.
2. Kudenchuk PJ, Brown SP, Daya M, et al. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest. N Engl J Med 2016.
3. Inghammar M, Svanström H, Melbye M, et al. Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study. BMJ 2016; 352:i843.
4. Santhanakrishnan R, Wang N, Larson MG, et al. Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction. Circulation 2016; 133:484.
5. Di Biase L, Burkhardt JD, Lakkireddy D, et al. Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial. J Am Coll Cardiol 2015; 66:2872.
6. Marijon E, Uy-Evanado A, Dumas F, et al. Warning Symptoms Are Associated With Survival From Sudden Cardiac Arrest. Ann Intern Med 2016; 164:23.
7. Siegal DM, Curnutte JT, Connolly SJ, et al. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity. N Engl J Med 2015; 373:2413.
8. Amsallem M, Sternbach JM, Adigopula S, et al. Addressing the Controversy of Estimating Pulmonary Arterial Pressure by Echocardiography. J Am Soc Echocardiogr 2016; 29:93.
9. Zheng Z, Jayaram R, Jiang L, et al. Perioperative Rosuvastatin in Cardiac Surgery. N Engl J Med 2016; 374:1744.
10. Velazquez EJ, Lee KL, Jones RH, et al. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. N Engl J Med 2016; 374:1511.
11. Kelbaek H. Deferred versus conventional stent implantation. Lancet 2016. 12. Tegn N, Abdelnoor M, Aaberge L, et al. Invasive versus conservative strategy in patients aged
80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial. Lancet 2016; 387:1057.
13. Sardella G, Lucisano L, Garbo R, et al. Single-Staged Compared With Multi-Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial. J Am Coll Cardiol 2016; 67:264.
14. Kubica J, Adamski P, Ostrowska M, et al. Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial. Eur Heart J 2016; 37:245.
15. Cung TT, Morel O, Cayla G, et al. Cyclosporine before PCI in Patients with Acute Myocardial Infarction. N Engl J Med 2015; 373:1021.
16. Ottani F, Latini R, Staszewsky L, et al. Cyclosporine A in Reperfused Myocardial Infarction: The Multicenter, Controlled, Open-Label CYCLE Trial. J Am Coll Cardiol 2016; 67:365.
17. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127:e362.
18. Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. J Am Coll Cardiol 2016; 67:1235.
19. McMurray J, Krum H, Abraham WT. Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure. N Engl J Med 2016.
20. Nielsen PB, Larsen TB, Gorst-Rasmussen A, et al. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study. Circ Heart Fail 2016; 9:e002597.
21. Lu M, Du H, Gao Z, et al. Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: An Echocardiography and Cardiovascular Magnetic Resonance Imaging Study. Circ Cardiovasc Interv 2016; 9.
22. Behrens I, Basit S, Lykke JA, et al. Association Between Hypertensive Disorders of Pregnancy and Later Risk of Cardiomyopathy. JAMA 2016; 315:1026.
23. Li L, Li S, Deng K, et al. Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies. BMJ 2016; 352:i610.
24. Redfield MM, Anstrom KJ, Levine JA, et al. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. N Engl J Med 2015; 373:2314.
25. Liebregts M, Vriesendorp PA, Mahmoodi BK, et al. A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy. JACC Heart Fail 2015; 3:896.
26. Cowie MR, Woehrle H, Wegscheider K, et al. Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. N Engl J Med 2015; 373:1095.
27. Aurora RN, Bista SR, Casey KR, et al. Updated Adaptive Servo-Ventilation Recommendations for the 2012 AASM Guideline: "The Treatment of Central Sleep Apnea Syndromes in Adults: Practice Parameters with an Evidence-Based Literature Review and Meta-Analyses". J Clin Sleep Med 2016.
28. Black S, Nicolay U, Del Giudice G, Rappuoli R. Influence of Statins on Influenza Vaccine Response in Elderly Individuals. J Infect Dis 2016; 213:1224.
29. Omer SB, Phadke VK, Bednarczyk RA, et al. Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness. J Infect Dis 2016; 213:1216.
30. Ware JS, Li J, Mazaika E, et al. Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med 2016; 374:233.
31. Howard G, Roubin GS, Jansen O, et al. Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials. Lancet 2016; 387:1305.
32. Rosenfield K, Matsumura JS, Chaturvedi S, et al. Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis. N Engl J Med 2016; 374:1011.
33. Bonaca MP, Gutierrez JA, Creager MA, et al. Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50). Circulation 2016; 133:997.
34. Laird JR, Schneider PA, Tepe G, et al. Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA. J Am Coll Cardiol 2015; 66:2329.
35. Lonn EM, Bosch J, López-Jaramillo P, et al. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med 2016.
36. Rana JS, Liu JY, Moffet HH, et al. Diabetes and Prior Coronary Heart Disease are Not Necessarily Risk Equivalent for Future Coronary Heart Disease Events. J Gen Intern Med 2016; 31:387.
37. Siu AL, U S Preventive Services Task Force. Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2015; 163:861.
38. Yeh RW, Secemsky EA, Kereiakes DJ, et al. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA 2016; 315:1735.
39. Myles PS, Smith JA, Forbes A, et al. Stopping vs. Continuing Aspirin before Coronary Artery Surgery. N Engl J Med 2016; 374:728.
40. Hermiller JB, Krucoff MW, Kereiakes DJ, et al. Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents. JACC Cardiovasc Interv 2016; 9:138.
41. Andò G, Capodanno D. Radial Versus Femoral Access in Invasively Managed Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysis. Ann Intern Med 2015; 163:932.
42. Cassese S, Byrne RA, Ndrepepa G, et al. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials. Lancet 2016; 387:537.
43. Hong SJ, Kim BK, Shin DH, et al. Effect of Intravascular Ultrasound-Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial. JAMA 2015; 314:2155.
44. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2016; 374:1609.
45. Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 2016.
46. Smith PK, Puskas JD, Ascheim DD, et al. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 2014; 371:2178.
47. Michler RE. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 2016.
48. Kodali S, Williams MR, Doshi D, et al. Sex-Specific Differences at Presentation and Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement: A Cohort Study. Ann Intern Med 2016; 164:377.
49. Sorajja P, Mack M, Vemulapalli S, et al. Initial Experience With Commercial Transcatheter Mitral Valve Repair in the United States. J Am Coll Cardiol 2016; 67:1129.
50. Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med 2016; 374:344.
Upcoming Lunchtime Drop-in Sessions
June (12pm)
Weds 8th Understanding articles
Thurs 16th Statistics
Fri 24th Information resources
May (1pm)
Weds 4th Understanding articles
Thurs 12th Statistics
Fri 20th Information resources
Tues 31st Literature Searching
The Library and Information Service provides free specialist information skills training for
all UHBristol staff and students. To book a place, email: [email protected]
If you’re unable to attend we also provide one-to-one or small group sessions. Contact
[email protected] or [email protected] to arrange a session.
UpToDate is the leading evidence-based clinical decision support system, designed for use at the point of care.
It contains more than 9,500 searchable topics across the following specialities:
Adult and paediatric emergency medicine Allergy and immunology Cardiovascular medicine Dermatology Drug therapy Endocrinology and diabetes mellitus Family medicine Gastroenterology and hepatology General surgery Geriatrics Haematology Hospital Medicine Infectious diseases Nephrology and hypertension Neurology Obstetrics and gynaecology Oncology Paediatrics Primary care internal medicine Psychiatry Pulmonary, critical care and sleep medicine Rheumatology
How to access UpToDate
You can access UpToDate from any computer via www.uptodate.com.
You will need your NHS Athens username/password (register through http://openathens.nice.org.uk/).
Literature Search A new topic can be chosen every month/quarter to reflect changes in practice or new developments in any particular field of interest. This section can be changed
Library Opening Times Staffed times 8.30 am—16.30 pm Monday to Friday Swipe Access 7.00 am—23.00pm 7 days a week Level 5, Education Centre University Hospitals Bristol Contact your outreach librarian Helen Pullen [email protected]